BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24948593)

  • 1. Counterpublic health and the design of drug services for methamphetamine consumers in Melbourne.
    Duff C; Moore D
    Health (London); 2015 Jan; 19(1):51-66. PubMed ID: 24948593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Science and scepticism: Drug information, young men and counterpublic health.
    Farrugia A; Fraser S
    Health (London); 2017 Nov; 21(6):595-615. PubMed ID: 26865213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enacting multiple methamphetamines: the ontological politics of public discourse and consumer accounts of a drug and its effects.
    Dwyer R; Moore D
    Int J Drug Policy; 2013 May; 24(3):203-11. PubMed ID: 23540297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exploration of self-perceived non-problematic use as a barrier to professional support for methamphetamine users.
    Quinn B; Stoové M; Papanastasiou C; Dietze P
    Int J Drug Policy; 2013 Nov; 24(6):619-23. PubMed ID: 23867050
    [No Abstract]   [Full Text] [Related]  

  • 5. Kalaban: Young drug users' engagements with law enforcement in the Philippines.
    Lasco G
    Int J Drug Policy; 2018 Feb; 52():39-44. PubMed ID: 29227882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new survey of methamphetamine users in treatment: who they are, why they like "meth," and why they need additional services.
    Maxwell JC
    Subst Use Misuse; 2014 May; 49(6):639-44. PubMed ID: 24093526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Just not all ice users do that": investigating perceptions and potential harms of Australia's Ice Destroys Lives campaign in two studies.
    Douglass CH; Early EC; Wright CJC; Palmer A; Higgs P; Quinn B; Dietze PM; Lim MSC
    Harm Reduct J; 2017 Jul; 14(1):45. PubMed ID: 28705259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary health-care responses to methamphetamine use in Australian Indigenous communities.
    MacLean S; Harney A; Arabena K
    Aust J Prim Health; 2015; 21(4):384-90. PubMed ID: 25704260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation into methamphetamine use: qualitative findings from an exploration of first time use among a group of New Zealand users.
    Sheridan J; Butler R; Wheeler A
    J Psychoactive Drugs; 2009 Mar; 41(1):11-7. PubMed ID: 19455905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of methamphetamine use and restrictive interventions in an acute adult inpatient mental health unit: A retrospective cohort study.
    McKenna B; McEvedy S; Kelly K; Long B; Anderson J; Dalzell E; Maguire T; Tacey M; Furness T
    Int J Ment Health Nurs; 2017 Feb; 26(1):49-55. PubMed ID: 27860236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with professional support access among a prospective cohort of methamphetamine users.
    Quinn B; Stoové M; Dietze P
    J Subst Abuse Treat; 2013 Aug; 45(2):235-41. PubMed ID: 23522848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From opiates to methamphetamine: building new harm reduction responses in Jakarta, Indonesia.
    Rigoni R; Woods S; Breeksema JJ
    Harm Reduct J; 2019 Dec; 16(1):67. PubMed ID: 31829253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysing pseudoephedrine/methamphetamine policy options in Australia using multi-criteria decision modelling.
    Manning M; Wong GT; Ransley J; Smith C
    Int J Drug Policy; 2016 Jun; 32():85-92. PubMed ID: 27179610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and public health Consequences of methamphetamine use in California's Central Valley.
    Gibson DR; Leamon MH; Flynn N
    J Psychoactive Drugs; 2002; 34(3):313-9. PubMed ID: 12422943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment.
    Cunningham JK; Liu LM
    Soc Sci Med; 2008 Apr; 66(7):1463-73. PubMed ID: 18222587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to methamphetamine withdrawal treatment in Australia: findings from a survey of AOD service providers.
    Pennay AE; Lee NK
    Drug Alcohol Rev; 2009 Nov; 28(6):636-40. PubMed ID: 19930017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of methamphetamine abuse beyond individual users.
    Watanabe-Galloway S; Ryan S; Hansen K; Hullsiek B; Muli V; Malone AC
    J Psychoactive Drugs; 2009 Sep; 41(3):241-8. PubMed ID: 19999677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine strategy requires evaluation.
    Wood E; Kerr T
    CMAJ; 2008 Sep; 179(7):677. PubMed ID: 18809901
    [No Abstract]   [Full Text] [Related]  

  • 20. Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia.
    Wallace C; Galloway T; McKetin R; Kelly E; Leary J
    Drug Alcohol Rev; 2009 Nov; 28(6):592-9. PubMed ID: 19930011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.